RAFAEL
DELGADO VÁZQUEZ
Profesor titular de universidad
Hospital Universitario La Paz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (26)
2023
-
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2
Viruses, Vol. 15, Núm. 7
-
Multifrequency Nanomechanical Mass Spectrometer Prototype for Measuring Viral Particles Using Optomechanical Disk Resonators
Proceedings of the IEEE International Conference on Micro Electro Mechanical Systems (MEMS)
-
Transmitted Drug Resistance to Integrase-Based First-Line Human Immunodeficiency Virus Antiretroviral Regimens in Mediterranean Europe
Clinical Infectious Diseases, Vol. 76, Núm. 9, pp. 1628-1635
2021
-
Detection of archived lamivudine-associated resistance mutations in virologically suppressed, lamivudine-experienced HIV-infected adults by different genotyping techniques (GEN-PRO study)
Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 12, pp. 3263-3271
-
Fever without source as the first manifestation of SARS-CoV-2 infection in infants less than 90 days old
European Journal of Pediatrics, Vol. 180, Núm. 7, pp. 2099-2106
-
Genomic epidemiology of SARS-CoV-2 in Madrid, Spain, during the first wave of the pandemic: Fast spread and early dominance by D614G variants
Microorganisms, Vol. 9, Núm. 2, pp. 1-11
-
Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study
The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 3, pp. 738-742
2019
-
Lower expression of plasma-derived exosome miR-21 levels in HIV-1 elite controllers with decreasing CD4 T cell count
Journal of Microbiology, Immunology and Infection, Vol. 52, Núm. 4, pp. 667-671
2018
-
Broad Neutralizing Activity Against Ebolaviruses Lacking the Mucin-Like Domain in Convalescent Plasma Specimens from Patients with Ebola Virus Disease
Journal of Infectious Diseases
-
Trends in Drug Resistance Prevalence, HIV-1 Variants and Clinical Status in HIV-1-infected Pediatric Population in Madrid: 1993 to 2015 Analysis
Pediatric Infectious Disease Journal, Vol. 37, Núm. 3, pp. e48-e57
2016
-
Convalescent plasma for ebola virus disease
New England Journal of Medicine
-
MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression
PLoS ONE, Vol. 11, Núm. 5
2015
-
Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 104.e1-104.e5
-
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5
2014
2012
-
Detection and quantification of the K103N mutation in HIV reverse transcriptase by pyrosequencing
Diagnostic Microbiology and Infectious Disease, Vol. 72, Núm. 1, pp. 90-96
2011
-
Molecular surveillance of HIV-1 in Madrid, Spain: A phylogeographic analysis
Journal of Virology, Vol. 85, Núm. 20, pp. 10755-10763
-
Single genome sequencing of HIV-1 gag and protease resistance mutations at virologic failure during the OK04 trial of simplified versus standard maintenance therapy
Antiviral Therapy, Vol. 16, Núm. 5, pp. 725-732
2010
-
Detection of HIV-1 at between 20 and 49 copies per milliliter by the Cobas TaqMan HIV-1 v2.0 assay is associated with higher pretherapy viral load and less time on antiretroviral therapy
Journal of Clinical Microbiology, Vol. 48, Núm. 5, pp. 1911-1912
2009
-
HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations
Journal of Antimicrobial Chemotherapy, Vol. 64, Núm. 2, pp. 251-258